Vas Narasimhan

Novartis CEO Vas Narasimhan discusses transforming the company into an innovative medicines giant. Topics include pharmaceutical innovations, AI in drug research, sustainability efforts, diversity & inclusion, and essential skills for CEOs. Insights on career growth in the pharmaceutical industry and market investment opportunities.

Novartis AG CEO discusses strong performance of established medicines and new drug launches. They explore market acceptance of a new cancer drug, company growth drivers, Swiss cultural identity, global operations, and strategic acquisitions in the pharmaceutical industry.

Vas Narasimhan, CEO of Novartis and leader at the world's largest medicine producer, shares insights on the pharmaceutical landscape. He discusses the balancing act of innovating while managing costs and the importance of early market signals for both big companies and startups. The conversation also explores advancements in gene therapies, the role of digital medicine in behavioral health, and the cultural shifts needed in pharma to embrace innovative therapies like RNA-based treatments. Narasimhan emphasizes collaboration between biotech startups and large firms for future success.